Kratom (Mitragyna speciosa)
What Is Kratom?
Botanists and formularies know Kratom as Mitragyna speciosa, a plant of the Rubiaceae family, native to Southeast Asia. The material in circulation is leaf — leafy growth taken above ground. Most people search for it simply as Kratom; suppliers, pharmacopoeias and interaction databases list it as Mitragyna speciosa, and matching the two is the first step in identifying what is actually in a product. In the hand it reads as bitter, herbaceous, green tea-like — a practical marker of freshness and correct identification.
Historically, Kratom was learned by hand: which stands to harvest, how to dry the leaf without spoiling it, and how much to use. Those observations were recorded generations before its compounds were named. Beyond its practical use it carries cultural associations — traditional plant medicine of Southeast Asian cultures and used by workers and fishermen as a daily ritual for resilience.
Today most searches for Kratom come from people reading about stress relief, sleep and pain relief, or checking how it sits alongside a medication they already take. The use most often documented in the literature is analgesic (mu-opioid receptor agonism by mitragynine), followed by self-reported opioid withdrawal management.
How Does Kratom Work?
Kratom is not a single active substance. Its chemistry is a mixture, and the fractions that researchers isolate most often are Alkaloids. Alkaloids is the fraction most often standardised in extracts, associated in the literature with bioactive nitrogen-containing compounds.
Before its chemistry was known, Kratom was judged by what it did in the cup: how strongly it brewed, how it tasted, and how little or much was needed. Those notes are why particular preparations survived and others did not.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 3 sources. Reported findings centre on No FDA-approved uses. Where research exists, it examines analgesic (mu-opioid receptor agonism by mitragynine), self-reported opioid withdrawal management and stimulant at low doses, sedative at high doses. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
Kratom is studied as a whole preparation because isolating one fraction tends to behave differently from the material it was taken out of — a recurring finding across the plant-chemistry literature.
Because these constituents are processed by the same pathways that handle many medicines, Kratom is documented as interacting with opioids, benzodiazepines and cyp2d6 substrates. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Kratom can differ substantially; this is why reference entries specify leaf and, where they exist, standardisation markers.